Cargando…

Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin

We have mined public genomic datasets to identify genes coding for components of the ubiquitin proteasome system (UPS) that may qualify as potential diagnostic and therapeutic targets in the three major glioma types, astrocytoma (AS), glioblastoma (GBM), and oligodendroglioma (ODG). In the Sun datas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vriend, Jerry, Klonisch, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079750/ https://www.ncbi.nlm.nih.gov/pubmed/35896929 http://dx.doi.org/10.1007/s10571-022-01261-0

Ejemplares similares

Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes
por: Vriend, Jerry, et al.
Publicado: (2022)

Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer
por: Vriend, Jerry, et al.
Publicado: (2021)

The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma
por: Vriend, Jerry, et al.
Publicado: (2015)

Dicer Deletion in Astrocytes Inhibits Oligodendroglial Differentiation and Myelination
por: Liu, Kun, et al.
Publicado: (2021)

Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma
por: Wang, Yun, et al.
Publicado: (2017)

Oligodendroglial myelination requires astrocyte-derived lipids
por: Camargo, Nutabi, et al.
Publicado: (2017)

Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas
por: Cryan, Jane B., et al.
Publicado: (2014)

Establishment of Prognostic Models for Astrocytic and Oligodendroglial Brain Tumors with Standardized Quantification of Marker Gene Expression and Clinical Variables
por: Zhou, Yi-Hong, et al.
Publicado: (2010)

Genetic markers in oligodendroglial tumours
por: Velnar, Tomaz, et al.
Publicado: (2010)

Beyond Myelination: Possible Roles of the Immune Proteasome in Oligodendroglial Homeostasis and Dysfunction
por: Madeira, Miguel M., et al.
Publicado: (2022)

The ubiquitin-proteasome system in glioma cell cycle control
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

Klotho increases antioxidant defenses in astrocytes and ubiquitin–proteasome activity in neurons
por: Orellana, Ana Maria, et al.
Publicado: (2023)

Prognostic Implication of Histological Oligodendroglial Tumor Component: Clinicopathological Analysis of 111 Cases of Malignant Gliomas
por: Kanno, Hiromi, et al.
Publicado: (2012)

Molecular Aberrations Associated with Seizure Control in Diffuse Astrocytic and Oligodendroglial Tumors
por: SUZUKI, Hime, et al.
Publicado: (2020)

DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases
por: Klonisch, Thomas, et al.
Publicado: (2023)

A CONFIRMATION OF THE OLIGODENDROGLIAL ORIGIN OF MYELIN IN THE ADULT RAT
por: Hirano, Asao
Publicado: (1968)

Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018)

Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic
por: Li, Yan-Xi, et al.
Publicado: (2016)

Role of Ubiquitin Ligases and Conjugases in Targeted Cancer Therapy
por: Vriend, Jerry
Publicado: (2023)

Gene Expression in Oligodendroglial Tumors
por: Shaw, Elisabeth J., et al.
Publicado: (2010)

Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis
por: Starost, Laura, et al.
Publicado: (2020)

HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
por: Đukić, Anamaria, et al.
Publicado: (2020)

Lipopolysaccharide Induces Degradation of Connexin43 in Rat Astrocytes via the Ubiquitin-Proteasome Proteolytic Pathway
por: Liao, Chih-Kai, et al.
Publicado: (2013)

Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination
por: Castillo-Rodriguez, Maria de los Angeles, et al.
Publicado: (2022)

The ubiquitin-proteasome pathway in cancer.
por: Spataro, V., et al.
Publicado: (1998)

The ubiquitin proteasome system in neuropathology
por: Lehman, Norman L.
Publicado: (2009)

The recognition of ubiquitinated proteins by the proteasome
por: Grice, Guinevere L., et al.
Publicado: (2016)

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention
por: Fhu, Chee Wai, et al.
Publicado: (2021)

Glioblastomas with Oligodendroglial Component – Common Origin of the Different Histological Parts and Genetic Subclassification
por: Klink, Barbara, et al.
Publicado: (2010)

Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin–proteasome pathway
por: Nie, Xiao-hu, et al.
Publicado: (2015)

The pineal gland: A model for adrenergic modulation of ubiquitin ligases
por: Vriend, Jerry, et al.
Publicado: (2017)

Protein Phosphatase Magnesium-Dependent 1δ (PPM1D) Expression as a Prognostic Marker in Adult Supratentorial Diffuse Astrocytic and Oligodendroglial Tumors
por: Jeong, Hui Jeong, et al.
Publicado: (2018)

Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma
por: Gu, Jun, et al.
Publicado: (2023)

Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities
por: Roussos, Panos, et al.
Publicado: (2014)

Oligodendroglial pathology in canine distemper
por: Zurbriggen, A., et al.
Publicado: (1997)

Oligodendroglial Heterogeneity in Neuropsychiatric Disease
por: Bøstrand, Sunniva M. K., et al.
Publicado: (2021)

The Ubiquitin Conjugating Enzyme: An Important Ubiquitin Transfer Platform in Ubiquitin-Proteasome System
por: Liu, Weigang, et al.
Publicado: (2020)

Poxvirus Exploitation of the Ubiquitin-Proteasome System
por: Barry, Michele, et al.
Publicado: (2010)

The Ubiquitin-Proteasome Pathway in Huntington's Disease
por: Mitra, Siddhartha, et al.
Publicado: (2008)

Enzymatic Blockade of the Ubiquitin-Proteasome Pathway
por: Ernst, Robert, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g33eff53n1mta8apaug6otuvgu